Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Monserrat Perez-Encinas"'
Autor:
Natalia Crespí-Villarías, Monserrat Perez-Encinas, Pedro Zarco-Montejo, Ramón Mazzucchelli, Patricia Sanmartin-Fenollera, Conrado M. Fernández-Rodríguez, Maria Velasco-Arribas, José Luis López-Estebaranz, José Lázaro Pérez-Calle, Elia Pérez-Fernández, Elena García-Zamora, Raquel Almodovar-Gonzalez, Javier Quirós-Donate, Pilar López-Serrano
ObjectiveTo estimate COVID-19 infection incidence rate with severe affectation (requiring hospitalization) in patients with biological treatment due to rheumatoid arthritis (RA), psoriatic arthritis (PsA), spondyloarthritis (SpA), psoriasis (Ps), and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de3f03b0b6282f299247a5948d599552
Autor:
Elia Pérez Fernández, Monserrat Perez Encinas, Karmele Arribalzaga Juaristi, Paloma Crespo-Robledo, Jose Javier Martínez Simón, Isabel Plo-Seco, Helena Quiros Ambel
Publikováno v:
European Journal of Hospital Pharmacy
Background Antithrombotic prophylaxis in hospitalised patients with SARS-CoV-2 acute infection has increased. Currently, most of the evidence relates to patients in intensive care units; however, there is little information on patients admitted to ho
Autor:
Patricia Sanmartin-Fenollera, Monserrat Perez-Encinas, Emma Bartolomé-García, Ángela Usarralde-Pérez
Publikováno v:
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Objectives To analyse persistence and adherence in patients with multiple sclerosis receiving first-line treatment with subcutaneous glatiramer acetate 20 mg (GA), subcutaneous interferon β1a (IFNβ1a-sc), intramuscular interferon β1a (IFNβ1a-im)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7ed0168dfa9ac62f6115c093a0d015b
https://hdl.handle.net/20.500.12530/41969
https://hdl.handle.net/20.500.12530/41969